(Q45888459)

17 December 2017

title

The effect of monoclonal or ion-exchange purified factor VIII concentrate on HIV disease progression: a prospective cohort comparison (English)

1 reference

17 December 2017

author name string

Hay CR

1

1 reference

17 December 2017

Ludlam CA

2

1 reference

17 December 2017

Lowe GD

3

1 reference

17 December 2017

Mayne EE

4

1 reference

17 December 2017

Lee RJ

5

1 reference

17 December 2017

Prescott RJ

6

1 reference

17 December 2017

Lee CA

7

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

17 December 2017

British Journal of Haematology

published in

1 reference

17 December 2017

volume

101

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

632-637

1 reference

17 December 2017

Incidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

Purity of factor VIII concentrates and serial CD4 counts. The Transfusion Safety Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

The natural history of human immunodeficiency virus infection in a haemophilic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

Protein content and factor VIII complex in untreated, treated and monoclonal factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

GUIDELINES ON THERAPEUTIC PRODUCTS TO TREAT HAEMOPHILIA AND OTHER HEREDITARY COAGULATION DISORDERS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

Mechanisms of inhibition of T cell IL-2 secretion by factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00753.X

10.1046/J.1365-2141.1998.00753.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017